Characterisation of drug resistant retroviral proteinase mutants.
Good
V M
VM
Department of Pharmaceutical and Biological Chemistry, School of Pharmacy, London, UK.
Anderson
M M
MM
Baker
J J
JJ
Moloudi
A
A
James
C H
CH
Wilderspin
A F
AF
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D016282:Aspartic Acid Endopeptidases / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000302:isolation & purification; D002846:Chromatography, Affinity; D004352:Drug Resistance, Microbial; D016333:HIV Protease / Q000737:chemistry; D008251:Macaca; D016297:Mutagenesis, Site-Directed; D011480:Protease Inhibitors / Q000494:pharmacology*; D011994:Recombinant Proteins / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000302:isolation & purification; D016415:Sequence Alignment; D017386:Sequence Homology, Amino Acid; D015302:Simian Immunodeficiency Virus / Q000187:drug effects* / Q000201:enzymology
D000998:Antiviral Agents; D011480:Protease Inhibitors; D011994:Recombinant Proteins; D016282:Aspartic Acid Endopeptidases; D016333:HIV Protease; C077164:SIV(mac) proteinase; C065184:p16 protease, Human immunodeficiency virus 2